Advertisement
Research Article

Personalized Prediction of Lifetime Benefits with Statin Therapy for Asymptomatic Individuals: A Modeling Study

  • Bart S. Ferket,

    Affiliations: Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands, Department of Radiology, Erasmus MC, Rotterdam, the Netherlands

    X
  • Bob J. H. van Kempen,

    Affiliations: Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands, Department of Radiology, Erasmus MC, Rotterdam, the Netherlands

    X
  • Jan Heeringa,

    Affiliation: Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands

    X
  • Sandra Spronk,

    Affiliations: Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands, Department of Radiology, Erasmus MC, Rotterdam, the Netherlands

    X
  • Kirsten E. Fleischmann,

    Affiliation: Department of Medicine, University of California, San Francisco, California, United States of America

    X
  • Rogier L. G. Nijhuis,

    Affiliation: Department of Cardiology, Ziekenhuisgroep Twente, Hengelo, the Netherlands

    X
  • Albert Hofman,

    Affiliation: Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands

    X
  • Ewout W. Steyerberg,

    Affiliation: Department of Public Health, Erasmus MC, Rotterdam, the Netherlands

    X
  • M. G. Myriam Hunink mail

    m.hunink@erasmusmc.nl

    Affiliations: Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands, Department of Radiology, Erasmus MC, Rotterdam, the Netherlands, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Published: December 27, 2012
  • DOI: 10.1371/journal.pmed.1001361

Reader Comments (2)

Post a new comment on this article